Less dyskinesia with ropinirole in early Parkinson's disease

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1239, 2000-01, pp. : 20-20

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ropinirole a good option in early Parkinson's disease?

By  

Inpharma, Vol. 1, Iss. 1245, 2000-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Ropinirole in the treatment of Parkinson’s disease

By Zesiewicz T.A.   Hauser R.A.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 5, 1999-05 ,pp. : 697-710

Informa Healthcare

Access to resources Recommend Favorite

Cabergoline, Pramipexole and Ropinirole Used as Monotherapy in Early Parkinson’s Disease: An Evidence-Based Comparison

By Inzelberg R.   Schechtman E.  

Drugs & Aging, Vol. 20, Iss. 11, 2003-01 ,pp. : 847-855

Adis International

Access to resources Recommend Favorite

Ropinirole Prolonged Release: In Advanced Parkinson's Disease

By Weber Juliane   Keating Gillian M.  

CNS Drugs, Vol. 23, Iss. 1, 2009-01 ,pp. : 81-90

Adis International

Access to resources Recommend Favorite

Ropinirole: A Review of its Use in the Management of Parkinson's Disease

By Matheson A.J.   Spencer C.M.  

Drugs, Vol. 60, Iss. 1, 2000-07 ,pp. : 115-137

Adis International

Access to resources Recommend Favorite